Q -- National Heart, Lung and Blood Institute Collaborative Effort with Inova Fairfax's Pulmonary Hypertension/Advanced Lung Disease Program

The National Institutes of Health (NIH), specifically the National Heart, Lung and Blood Institute (NHLBI), has a long history of an established integrative clinical research approach. The Pulmonary Vascular team at NHLBI consists of physicians with expertise in pulmonary, hematology, and cardiovascular diseases which represent critical components in the management of pulmonary arterial hypertension (PAH) patients. It is envisioned that the NIH will enter into a collaborative partnership with the Inova Fairfax Hospital (Inova) to participate in their well established Pulmonary Hypertension Program. The primary goal of this collaboration will be the development of a PAH research program based on clinical practice, research ingenuity, discovery and the transfer of knowledge. This arrangement will also provide a broad array of bench to bedside research ventures for the affected patient population. The patients recruited through NIH for study purposes would have the option of being followed/managed clinically through Inova's program. This notice of is not a request for competitive proposals. Interested parties may provide capability statements detailing their abilities. Any submissions received within ten (10) calendar days after publication of this synopsis will be considered by the Government. A determination by the Government not to compete this proposed award based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement".